Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beijing Tiantan Biological Products Days Payable Chart
SHSE:600161 vs VRTX, REGN, ALNY: Days Payable Comparison
For the Biotechnology subindustry, Beijing Tiantan Biological Products's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beijing Tiantan Biological Products Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Beijing Tiantan Biological Products's Days Payable distribution charts can be found below:
* The bar in red indicates where Beijing Tiantan Biological Products's Days Payable falls into.
Beijing Tiantan Biological Products Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beijing Tiantan Biological Products (SHSE:600161) has a Days Payable of 10.65 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Beijing Tiantan Biological Products and its competitors. This is 22% below median its historical median of 13.72. Over the past decade, Beijing Tiantan Biological Products' Days Payable has ranged from 8.58 to 46.38. According to the industry distribution chart, Beijing Tiantan Biological Products ranks #673 out of 701 companies in the Biotechnology industry, placing it in the top 96%.
Is Beijing Tiantan Biological Products' Days Payable too high?
Beijing Tiantan Biological Products' current Days Payable of 10.65 is 22% below median its 10-year median of 13.72. Over the past 10 years, this metric has ranged from a low of 8.58 to a high of 46.38. The Biotechnology industry median Days Payable is 112.84. Beijing Tiantan Biological Products' value of 10.65 is 90.6% below this industry median. Based on the distribution chart, Beijing Tiantan Biological Products ranks #673 out of 701 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Beijing Tiantan Biological Products has a GF Score™ of 75/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Beijing Tiantan Biological Products' Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Beijing Tiantan Biological Products ranks #673 out of 701 companies for Days Payable. This places Beijing Tiantan Biological Products in the lower half of its industry. The industry median Days Payable is 112.84. Beijing Tiantan Biological Products' value of 10.65 is 90.6% below this benchmark. Historically, Beijing Tiantan Biological Products' own Days Payable has ranged from 8.58 to 46.38 over the past decade. While the company's 10-year median is 13.72 vs. the industry median of 112.84, Beijing Tiantan Biological Products has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 112.84, based on 701 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Beijing Tiantan Biological Products's current Days Payable of 10.65 is 90.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Beijing Tiantan Biological Products and its competitors. For the Biotechnology industry, the median Days Payable is 112.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beijing Tiantan Biological Products's current Days Payable is 10.65, which is 22% below median its own 10-year median of 13.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beijing Tiantan Biological Products stock overvalued right now?
Based on GuruFocus' analysis, Beijing Tiantan Biological Products (SHSE:600161) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥23.94, compared to a current price of ¥12.95 — trading 45.9% below its estimated fair value. The current Days Payable is 10.65, which is 22% below median its 10-year median of 13.72 and 90.6% below the Biotechnology industry median of 112.84. Beijing Tiantan Biological Products' overall GF Score™ is 75/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Beijing Tiantan Biological Products (SHSE:600161), the current Days Payable is 10.65 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Beijing Tiantan Biological Products (SHSE:600161) Overvalued in 2026?
Based on GuruFocus' analysis, Beijing Tiantan Biological Products stock appears to be undervalued.
The current stock price of ¥12.95 is trading 45.9% below its estimated GF Value™ of ¥23.94.
GuruFocus considers Beijing Tiantan Biological Products to be Significantly Undervalued.
Key valuation signals for SHSE:600161:
Days Payable: 10.65 (22% below median its 10-year median of 13.72)
GF Value™: ¥23.94 vs. price of ¥12.95 (45.9% below fair value)
Industry Position: 90.6% below the Biotechnology median (#673 of 701)
No single metric tells the full story. See the SHSE:600161 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Beijing Tiantan Biological Products Business Description
Beijing Tiantan Biological Products Corp Ltd uses healthy human plasma and specifically immunized human plasma as raw materials and adopts genetic recombination technology to develop and produce blood products and engage in the blood product business. The company's main products include human albumin, human immunoglobulin (pH4) for intravenous injection, human hepatitis B immunoglobulin, human immunoglobulin, human rabies immunoglobulin, human histamine immunoglobulin, and others.
75GF Score
Get the complete analysis for SHSE:600161
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600161 has been successfully added to your 
